Synonyms
Definition
Hypertension is usually diagnosed when a person’s systolic blood pressure (SBP) in the office or clinic is ≥140 mmHg and/or their diastolic blood pressure (DBP) is ≥90 mmHg following repeated examinations (Williams et al. 2018; Unger et al. 2020). This is based on the evidence from multiple randomized controlled trials (RCTs) that treatment of patients with these blood pressure (BP) values is beneficial. The same definition is used in young, middle-aged, and older people, whereas BP centiles are used in children and teenagers, in whom data from interventional trials are not available (Williams et al. 2018). BP measurement is the fundamental means and method of evaluating BP level, diagnosing hypertension, and observing antihypertensive efficacy. Clinic and out-of-office BP measurements are adopted frequently in clinical practice and population disease prevention and control, the latter refers to ambulatory BP monitoring...
This is a preview of subscription content, log in via an institution to check access.
References
Aronow WS, Fleg JL, Pepine CJ et al (2011) ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens 5(4):259–352. https://doi.org/10.1016/j.jash.2011.06.001
Beckett NS, Peters R, Fletcher AE et al (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358(18):1887–1898. https://doi.org/10.1056/NEJMoa0801369
Brown MJ, Palmer CR, Castaigne A et al (2000) Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the international Nifedipine GITS study: intervention as a goal in hypertension treatment (INSIGHT). Lancet 356(9227):366–372. https://doi.org/10.1016/S0140-6736(00)02527-7
Chan Q, Stamler J, Griep LM et al (2016) An update on nutrients and blood pressure. J Atheroscler Thromb 23(3):276–289. https://doi.org/10.5551/jat.30000
Chaudhry SI, Krumholz HM, Foody JM (2004) Systolic hypertension in older persons. JAMA 292(9):1074–1080. https://doi.org/10.1001/jama.292.9.1074
Chow CK, Teo KK, Rangarajan S et al (2013) Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310(9):959–968. https://doi.org/10.1001/jama.2013.184182
Dhaun N, Webb DJ (2019) Endothelins in cardiovascular biology and therapeutics. Nat Rev Cardiol 16(8):491–502. https://doi.org/10.1038/s41569-019-0176-3
Dominiczak AF, Kuo D (2017) Hypertension: update 2017. Hypertension 69(1):3–4. https://doi.org/10.1161/HYPERTENSIONAHA.116.08683
Dong GH, Qian ZM, Xaverius PK et al (2013) Association between long-term air pollution and increased blood pressure and hypertension in China. Hypertension 61(3):578–584. https://doi.org/10.1161/HYPERTENSIONAHA.111.00003
Elijovich F, Weinberger MH, Anderson CA et al (2016) Salt sensitivity of blood pressure: a scientific statement from the American Heart Association. Hypertension 68(3):e7–e46. https://doi.org/10.1161/HYP.0000000000000047
Ettehad D, Emdin CA, Kiran A et al (2016) Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387(10022):957–967. https://doi.org/10.1016/S0140-6736(15)01225-8
Falaschetti E, Mindell J, Knott C et al (2014) Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet 383(9932):1912–1919. https://doi.org/10.1016/S0140-6736(14)60688-7
Ferrario CM, Jessup J, Chappell MC et al (2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111(20):2605–2610. https://doi.org/10.1161/CIRCULATIONAHA.104.510461
Flegal KM, Cauley JA (1985) Alcohol consumption and cardiovascular risk factors. Recent Dev Alcohol 3:165–180. https://doi.org/10.1007/978-1-4615-7715-7_13
Ford ES (2011) Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation 123(16):1737–1744. https://doi.org/10.1161/CIRCULATIONAHA.110.005645
Forman JP, Stampfer MJ, Curhan GC (2009) Diet and lifestyle risk factors associated with incident hypertension in women. JAMA 302(4):401–411. https://doi.org/10.1001/jama.2009.1060
Franklin SS, Lopez VA, Wong ND et al (2009) Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham heart study. Circulation 119(2):243–250. https://doi.org/10.1161/CIRCULATIONAHA.108.797936
Franklin SS, Wilkinson IB, McEniery CM (2012) Unusual hypertensive phenotypes: what is their significance? Hypertension 59(2):173–178. https://doi.org/10.1161/HYPERTENSIONAHA.111.182956
Fukutomi M, Kario K (2010) Aging and hypertension. Expert Rev Cardiovasc Ther 8(11):1531–1539. https://doi.org/10.1586/erc.10.78
Gao C, Cai Y, Zhang K et al (2020) Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J 41(22):2058–2066. https://doi.org/10.1093/eurheartj/ehaa433
Geldsetzer P, Manne-Goehler J, Marcus ME et al (2019) The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults. Lancet 394(10199):652–662. https://doi.org/10.1016/S0140-6736(19)30955-9
Gu D, Gupta A, Muntner P et al (2005) Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the international collaborative study of cardiovascular disease in Asia (InterAsia). Circulation 112(5):658–665. https://doi.org/10.1161/CIRCULATIONAHA.104.515072
Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271–280. https://doi.org/10.1016/j.cell.2020.02.052
Hubert HB, Feinleib M, McNamara PM et al (1983) Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 67(5):968–977. https://doi.org/10.1161/01.cir.67.5.968
Imai Y, Kuba K, Rao S et al (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436(7047):112–116. https://doi.org/10.1038/nature03712
Johansson JK, Niiranen TJ, Puukka PJ et al (2012) Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home study. Hypertension 59(2):212–218. https://doi.org/10.1161/HYPERTENSIONAHA.111.178657
Julius S, Weber MA, Kjeldsen SE et al (2006) The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy. Hypertension 48(3):385–391. https://doi.org/10.1161/01.HYP.0000236119.96301.f2
Kearney PM, Whelton M, Reynolds K et al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365(9455):217–223. https://doi.org/10.1016/S0140-6736(05)17741-1
Kjeldsen SE, Lund-Johansen P, Nilsson PM et al (2016) Unattended blood pressure measurements in the systolic blood pressure intervention trial: implications for entry and achieved blood pressure values compared with other trials. Hypertension 67(5):808–812. https://doi.org/10.1161/HYPERTENSIONAHA.116.07257
Klatsky AL (2010) Alcohol and cardiovascular mortality: common sense and scientific truth. J Am Coll Cardiol 55(13):1336–1338. https://doi.org/10.1016/j.jacc.2009.10.057
Lambert E, Dawood T, Straznicky N et al (2010) Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens 28(3):543–550. https://doi.org/10.1097/HJH.0b013e3283350ea4
Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665. https://doi.org/10.1136/bmj.b1665
Lesniak KT, Dubbert PM (2001) Exercise and hypertension. Curr Opin Cardiol 16(6):356–359. https://doi.org/10.1097/00001573-200111000-00007
Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903–1913. https://doi.org/10.1016/s0140-6736(02)11911-8
Lindholm LH, Carlberg B, Samuelsson O (2005) Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 366(9496):1545–1553. https://doi.org/10.1016/S0140-6736(05)67573-3
Liu L, Zhang Y, Liu G et al (2005) The Felodipine event reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens 23(12):2157–2172. https://doi.org/10.1097/01.hjh.0000194120.42722.ac
Liu J, Sui X, Lavie CJ et al (2014) Effects of cardiorespiratory fitness on blood pressure trajectory with aging in a cohort of healthy men. J Am Coll Cardiol 64(12):1245–1253. https://doi.org/10.1016/j.jacc.2014.06.1184
Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension. Blood Press 22(4):193–278. https://doi.org/10.3109/08037051.2013.812549
Mann JF, Schmieder RE, McQueen M et al (2008) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372(9638):547–553. https://doi.org/10.1016/S0140-6736(08)61236-2
Mente A, O’Donnell MJ, Rangarajan S et al (2014) Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med 371(7):601–611. https://doi.org/10.1056/NEJMoa1311989
Morra ME, Van Thanh L, Kamel MG et al (2018) Clinical outcomes of current medical approaches for middle east respiratory syndrome: a systematic review and meta-analysis. Rev Med Virol 28(3):e1977. https://doi.org/10.1002/rmv.1977
O’Donnell MJ, Chin SL, Rangarajan S et al (2016) Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 388(10046):761–775. https://doi.org/10.1016/S0140-6736(16)30506-2
Pan Y, Cai W, Cheng Q et al (2015) Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies. Neuropsychiatr Dis Treat 11:1121–1130. https://doi.org/10.2147/NDT.S77710
Reynolds HR, Adhikari S, Pulgarin C et al (2020) Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMoa2008975
Sheng CS, Liu M, Zeng WF et al (2013) Four-limb blood pressure as predictors of mortality in elderly Chinese. Hypertension 61(6):1155–1160. https://doi.org/10.1161/HYPERTENSIONAHA.111.00969
Takase H, Sugiura T, Kimura G et al (2015) Dietary sodium consumption predicts future blood pressure and incident hypertension in the Japanese normotensive general population. J Am Heart Assoc 4(8):e1959. https://doi.org/10.1161/JAHA.115.001959
Unger T, Borghi C, Charchar F et al (2020) 2020 international society of hypertension global hypertension practice guidelines. Hypertension 75(6):1334–1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585
Whelton PK (2014) Sodium, potassium, blood pressure, and cardiovascular disease in humans. Curr Hypertens Rep 16(8):465. https://doi.org/10.1007/s11906-014-0465-5
Whelton PK, Appel LJ, Sacco RL et al (2012) Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation 126(24):2880–2889. https://doi.org/10.1161/CIR.0b013e318279acbf
Williams B, Mancia G, Spiering W et al (2018) 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J 39(33):3021–3104. https://doi.org/10.1093/eurheartj/ehy339
Wright JJ, Williamson JD, Whelton PK et al (2015) A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373(22):2103–2116. https://doi.org/10.1056/NEJMoa1511939
Yusuf S, Teo KK, Pogue J et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358(15):1547–1559. https://doi.org/10.1056/NEJMoa0801317
Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Ding, C., Luo, L., Huang, X. (2020). Hypertension. In: Gu, D., Dupre, M. (eds) Encyclopedia of Gerontology and Population Aging. Springer, Cham. https://doi.org/10.1007/978-3-319-69892-2_1046-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-69892-2_1046-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-69892-2
Online ISBN: 978-3-319-69892-2
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences